News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
7,535 Results
Type
Article (1159)
Company Profile (1)
Press Release (6375)
Multimedia
Podcasts (5)
Webinars (3)
Section
Business (2976)
Career Advice (41)
Deals (465)
Drug Development (1268)
Employer Resources (15)
FDA (218)
Job Trends (339)
News (4765)
Policy (389)
Tag
Academia (25)
Accelerated approval (2)
Adcomms (1)
Allergies (1)
Alliances (802)
ALS (1)
Alzheimer's disease (14)
Antibody-drug conjugate (ADC) (7)
Approvals (216)
Artificial intelligence (4)
Autoimmune disease (1)
Bankruptcy (5)
Best Places to Work (222)
BIOSECURE Act (2)
Biosimilars (2)
Breast cancer (1)
Cancer (40)
Cardiovascular disease (2)
Career advice (28)
Career pathing (2)
CAR-T (3)
Cell therapy (6)
Clinical research (1067)
Collaboration (20)
Compensation (2)
Complete response letters (1)
COVID-19 (55)
C-suite (16)
Data (35)
Depression (4)
Diabetes (2)
Diagnostics (29)
Diversity, equity & inclusion (6)
Drug discovery (6)
Drug pricing (4)
Duchenne muscular dystrophy (4)
Earnings (857)
Editorial (3)
Employer branding (4)
Employer resources (14)
Events (804)
Executive appointments (36)
FDA (237)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (12)
Gene editing (1)
Generative AI (1)
Gene therapy (7)
GLP-1 (21)
Government (54)
Guidances (5)
Healthcare (175)
Huntington's disease (2)
IgA nephropathy (1)
Immunology and inflammation (6)
Infectious disease (56)
Inflammatory bowel disease (7)
Interviews (5)
IPO (198)
IRA (1)
Job creations (101)
Job search strategy (24)
Kidney cancer (1)
Labor market (6)
Layoffs (24)
Legal (99)
Lung cancer (1)
Lymphoma (5)
Management (2)
Manufacturing (9)
Medical device (15)
Medtech (15)
Mergers & acquisitions (270)
Metabolic disorders (2)
Neurodegenerative disease (4)
Neuropsychiatric disorders (4)
Neuroscience (33)
NextGen: Class of 2025 (81)
Non-profit (54)
Now hiring (29)
Obesity (1)
Opinion (12)
Pain (1)
Patents (1)
Patient recruitment (2)
Peanut (1)
People (1191)
Pharmaceutical (2)
Phase I (290)
Phase II (387)
Phase III (527)
Pipeline (26)
Policy (6)
Postmarket research (55)
Preclinical (82)
Prostate cancer (2)
Radiopharmaceuticals (3)
Rare diseases (10)
Real estate (75)
Recruiting (5)
Regulatory (293)
Research institute (28)
Resumes & cover letters (5)
Schizophrenia (3)
Series A (4)
Series B (1)
Sickle cell disease (2)
Special edition (2)
Spinal muscular atrophy (4)
Startups (91)
Tariffs (7)
The Weekly (5)
Vaccines (15)
Venture capital (3)
Weight loss (1)
Women's health (2)
Date
Today (2)
Last 7 days (8)
Last 30 days (27)
Last 365 days (370)
2025 (215)
2024 (489)
2023 (526)
2022 (767)
2021 (915)
2020 (867)
2019 (540)
2018 (416)
2017 (451)
2016 (375)
2015 (418)
2014 (247)
2013 (198)
2012 (226)
2011 (200)
2010 (163)
Location
Africa (15)
Alabama (3)
Asia (1243)
Australia (28)
California (99)
Canada (20)
China (17)
Colorado (3)
Connecticut (3)
Delaware (7)
Europe (1229)
Florida (7)
Georgia (2)
Illinois (24)
Indiana (4)
Japan (14)
Maryland (21)
Massachusetts (81)
Michigan (1)
Minnesota (2)
New Hampshire (3)
New Jersey (23)
New Mexico (1)
New York (8)
North Carolina (5)
Northern California (49)
Ohio (2)
Pennsylvania (6)
Rhode Island (1)
South America (15)
South Carolina (1)
Southern California (28)
Tennessee (1)
Texas (4)
United States (288)
Virginia (1)
Washington State (6)
7,535 Results for "takeda".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Neuroscience
Takeda Establishes Lead in Narcolepsy Race With Back-to-Back Phase III Wins
Takeda’s oveporexton improved wakefulness, attention and other key narcolepsy endpoints “with a high degree of statistical significance,” according to Jefferies analysts.
July 14, 2025
·
2 min read
·
Tristan Manalac
Earnings
Takeda Pledges $30B in U.S., Argues Against Trump’s ‘Most Favored Nation’ Proposal
Takeda’s Julie Kim argues that Trump’s idea to match drug prices to that of other countries could cost the industry up to $1 trillion over the next 10 years.
May 8, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Takeda Announces New Assignments of Directors
June 25, 2025
·
6 min read
Collaboration
Takeda Pumps $770M Into Another BridGene Pact to Hit ‘Undruggable’ Targets
BridGene strikes another partnership with Takeda as the latter company continues its dealmaking streak, following high-ticket agreements with Keros Therapeutics, AC Immune and Degron Therapeutics in the past nine months.
February 25, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Takeda Announces First-Quarter FY2025 Results With Significant Late-Stage Pipeline Progression
July 30, 2025
·
10 min read
Phase III
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial
Protagonist Therapeutics notches a milestone in its pact with Takeda for rusfertide. New data show that many patients with a chronic blood cancer taking the drug didn’t need to have their blood removed to bring down dangerously high hemocrit levels.
March 3, 2025
·
2 min read
·
Annalee Armstrong
Business
Takeda Drops Epilepsy Drug, Names New CEO Amid Q3 Earnings
Analysts were unfazed by the news that Takeda will cease development of soticlestat after Phase III failures, while responding positively to the announcement that Julie Kim will take the helm of the Japanese giant in 2026.
January 30, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Takeda Receives FDA 510(k) Clearance for HyHubTM and HyHubTM Duo Devices to Simplify HYQVIA® Administration
July 21, 2025
·
15 min read
Press Releases
Takeda Announces Positive Results from Two Pivotal Phase 3 Studies of Oveporexton (TAK-861) in Narcolepsy Type 1
July 14, 2025
·
11 min read
Press Releases
Takeda and Nature Announce Call for Applications Now Open for 2026 Innovators in Science Award
May 28, 2025
·
8 min read
1 of 754
Next
